PDGFRB and ovarian serous adenocarcinoma: In human breast cancer, isolation of a FAP+PDGFRβ+ CAF subset was shown to promote survival and differentiation of inhibitory Tregs via both a cell contact and paracrine mechanism involving CXCL1245 and was extended to mesenchymal high-grade serous ovarian cancers.46